Valve-in-valve transcatheter aortic valve replacement or re-surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
Francesco BrunoEdoardo EliaFabrizio D'AscenzoGiorgio MarengoPierre DeharoTsuyoshi KanekoThomas CuissetLaurent FauchierOvidio De FilippoGuglielmo GalloneAlessandro AndreisFederico FortuniStefano SalizzoniMichele La TorreMauro RinaldiGaetano M De FerrariFederico ConrottoPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
In high- and intermediate-risk patients with degenerated surgical bioprostheses, ViV TAVI is associated with reduced short-term mortality, compared with re-SAVR. Nevertheless, no differences were found in all-cause and CV mortality at midterm follow-up. PROSPERO CRD42021226488.